RPP30 and pancreatic adenocarcinoma: These data also show that there is no significant difference in RPP30 expression levels in different stages of those tumors while high expression of RPP30 is correlated with lower overall survival in PAAD using data from the GEPIA2 public database (http://gepia2.cancer-pku.cn/#index).